相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β
Mikoto Tanabe et al.
LEUKEMIA (2022)
CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer
Kai Adachi et al.
VIRCHOWS ARCHIV (2022)
Reversine suppresses osteosarcoma cell growth through targeting BMP-Smad1/5/8-mediated angiogenesis
Lingzhi Hu et al.
MICROVASCULAR RESEARCH (2021)
CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity
Pauliina Filppu et al.
JCI INSIGHT (2021)
Magnesium ions regulate mesenchymal stem cells population and osteogenic differentiation: A fuzzy agent-based modeling approach
Jalil Nourisa et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine
Adriana C. Gamboa et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Joseph K. Kendal et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2020)
CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma
Xue-Tang Mo et al.
BRITISH JOURNAL OF CANCER (2020)
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling
Tetsuro Taki et al.
CANCER SCIENCE (2020)
Sarcoma treatment in the era of molecular medicine
Thomas G. P. Grunewald et al.
EMBO MOLECULAR MEDICINE (2020)
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Yan Zhou et al.
NATURE COMMUNICATIONS (2020)
Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathway
Haijun Tian et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2019)
CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis
Shinji Mii et al.
PATHOLOGY INTERNATIONAL (2019)
CD109 deficiency induces osteopenia with an osteoporosis-like phenotype in vivo
Shinji Mii et al.
GENES TO CELLS (2018)
Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling
Yuan-Li Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma
Maki Yokoyama et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin
Joshua Vorstenbosch et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Significance of perivascular tumour cells defined by CD109 expression in progression of glioma
Yukihiro Shiraki et al.
JOURNAL OF PATHOLOGY (2017)
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis
Chen-Hua Chuang et al.
NATURE MEDICINE (2017)
Myxofibrosarcoma primary cultures: molecular and pharmacological profile
Alessandro De Vita et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
The effect of bone morphogenetic protein-2 on osteosarcoma metastasis
Jonathan Gill et al.
PLOS ONE (2017)
Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses
Carter Li et al.
BIOCHEMICAL JOURNAL (2016)
Suppression of skin tumorigenesis in CD109-deficient mice
Masaki Sunagawa et al.
ONCOTARGET (2016)
Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure
Hiroki Miyachi et al.
JOURNAL OF VASCULAR SURGERY (2014)
Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion
Zilan Lv et al.
MOLECULES AND CELLS (2013)
High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
Makoto Emori et al.
PLOS ONE (2013)
Epidermal Hyperplasia and Appendage Abnormalities in Mice Lacking CD109
Shinji Mii et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors
Albane A. Bizet et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis
Ivan V. Litvinov et al.
EXPERIMENTAL DERMATOLOGY (2011)
Processing of CD109 by furin and its role in the regulation of TGF-β signaling
S. Hagiwara et al.
ONCOGENE (2010)
Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2
Stefano Zanotti et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells
Masaki Hasegawa et al.
PATHOLOGY INTERNATIONAL (2007)
Identification of CD109 as part of the TGF-β receptor system in human keratinocytes
Kenneth W. Finnson et al.
FASEB JOURNAL (2006)
Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins
M Lin et al.
BLOOD (2002)
Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2
J Lou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
